Home › Funds › Capricorn Fund Managers Ltd › WST
Capricorn Fund Managers Ltd position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
Capricorn Fund Managers Ltd reported holding 43,467 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$16.1M, representing 1.54% of its reported portfolio and ranking #18 among its reported holdings. Capricorn Fund Managers Ltd has disclosed WST holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Capricorn Fund Managers Ltd's WST position evolved
Capricorn Fund Managers Ltd first disclosed a stake in WST in Q2 2026 at 18,700 shares (US$6.7M). The position peaked in Q3 2026 at 43,467 shares, worth US$16.1M. Across 2 filings, Capricorn Fund Managers Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 43,467 shares valued at US$16.1M — an increase of 24,767 shares quarter over quarter.. Notable position changes include a 132% increase in Q3 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 18.70K | $6.71M | New |
| Q3 2026 | 43.47K | $16.12M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WST and 13F data
WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WST
- Artisan Partners Limited Partnership 2.01M sh · $744.42M · Q3 2026
- GENERATION INVESTMENT MANAGEMENT LLP 2.03M sh · $728.17M · Q2 2026
- BROWN ADVISORY INC 1.08M sh · $386.04M · Q2 2026
- Longview Partners (Guernsey) LTD 1.03M sh · $371.14M · Q2 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 760.62K sh · $273.06M · Q2 2026
More on Capricorn Fund Managers Ltd
FAQ
How long has Capricorn Fund Managers Ltd held WST?
Capricorn Fund Managers Ltd has disclosed WST holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Capricorn Fund Managers Ltd's current position in WST?
As of Q3 2026, Capricorn Fund Managers Ltd holds 43.47K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $16.12M, representing 1.54% of its reported portfolio and ranking #18.
Has Capricorn Fund Managers Ltd been buying or selling WST?
In the latest 13F filing (Q3 2026), Capricorn Fund Managers Ltd increased its position in WST. The position peaked in Q3 2026 at 43.47K shares.
Which other funds hold WST?
Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.